BiomarkersIn silico
AI‐driven Amyloid Pathology Detection Using Multi‐modal MRI: A Proof of Concept Study
AAIC 2025 Abstract
Abstract
Background: Traditional methods for detecting Alzheimer's disease (AD) pathology are often expensive, invasive, and inaccessible. Early identification of AD biomarkers is critical to enable timely and effective interventions that improve patient outcomes.



